tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ionis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
PremiumRatingsIonis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
1M ago
Ionis Advances Bepirovirsen After Positive Phase 3 Results
Premium
Company Announcements
Ionis Advances Bepirovirsen After Positive Phase 3 Results
1M ago
Ionis partner GSK reports B-Well 1, B-Well 2 studies met primary endpoint
Premium
The Fly
Ionis partner GSK reports B-Well 1, B-Well 2 studies met primary endpoint
1M ago
Ionis Pharmaceuticals price target raised to $95 from $82 at RBC Capital
PremiumThe FlyIonis Pharmaceuticals price target raised to $95 from $82 at RBC Capital
2M ago
Arrowhead price target raised to $100 from $70 at Piper Sandler
Premium
The Fly
Arrowhead price target raised to $100 from $70 at Piper Sandler
2M ago
Ionis Pharmaceuticals price target raised to $100 from $85 at Leerink
Premium
The Fly
Ionis Pharmaceuticals price target raised to $100 from $85 at Leerink
2M ago
Arrowhead price target raised to $48 from $27 at Goldman Sachs
PremiumThe FlyArrowhead price target raised to $48 from $27 at Goldman Sachs
3M ago
Ionis Pharmaceuticals Completes $770M Convertible Notes Offering
Premium
Company Announcements
Ionis Pharmaceuticals Completes $770M Convertible Notes Offering
3M ago
Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
Premium
The Fly
Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100